111 related articles for article (PubMed ID: 2433727)
21. Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma.
Brechot C; Pourcel C; Louise A; Rain B; Tiollais P
Nature; 1980 Jul; 286(5772):533-5. PubMed ID: 6250074
[TBL] [Abstract][Full Text] [Related]
22. Effects of suramin on in vitro HBsAg production by PLC/PRF/5 cells and hepatitis B virus DNA polymerase activity.
Kessler HA; Pottage JC; Trenholme GM; Benson CA; Levin S
AIDS Res; 1986 Feb; 2(1):63-72. PubMed ID: 2424468
[TBL] [Abstract][Full Text] [Related]
23. Specific uptake of asialofetuin-tacked liposomes encapsulating interferon-gamma by human hepatoma cells and its inhibitory effect on hepatitis B virus replication.
Ishihara H; Hayashi Y; Hara T; Aramaki Y; Tsuchiya S; Koike K
Biochem Biophys Res Commun; 1991 Jan; 174(2):839-45. PubMed ID: 1704230
[TBL] [Abstract][Full Text] [Related]
24. Effects of transforming growth factor-beta 1 against the inhibitory action of interferon on DNA synthesis and viral replication in hepatitis B virus DNA-transfected cell.
Kakumu S; Ito Y; Wakita T; Yoshioka K; Ishikawa T; Takayanagi M; Higashi Y; Yang ZQ
J Med Virol; 1992 Sep; 38(1):62-6. PubMed ID: 1383417
[TBL] [Abstract][Full Text] [Related]
25. Induction of immune tolerance toward tumor-associated-antigens enables growth of human hepatoma in mice.
Gotsman I; Israeli D; Alper R; Rabbani E; Engelhardt D; Ilan Y
Int J Cancer; 2002 Jan; 97(1):52-7. PubMed ID: 11774243
[TBL] [Abstract][Full Text] [Related]
26. Integration of hepatitis B virus sequences and their expression in a human hepatoma cell.
Edman JC; Gray P; Valenzuela P; Rall LB; Rutter WJ
Nature; 1980 Jul; 286(5772):535-8. PubMed ID: 6250075
[TBL] [Abstract][Full Text] [Related]
27. Identification of integrated hepatitis B virus DNA sequences in human hepatocellular carcinomas.
Shafritz DA; Kew MC
Hepatology; 1981; 1(1):1-8. PubMed ID: 6269974
[TBL] [Abstract][Full Text] [Related]
28. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
29. Nondetection of infectious hepatitis B virus in a human hepatoma cell line producing hepatitis B surface antigen.
Tabor E; Copeland JA; Mann GF; Howard CR; Skelly J; Snoy P; Zuckerman AJ; Gerety RJ
Intervirology; 1981; 15(2):82-6. PubMed ID: 7298300
[TBL] [Abstract][Full Text] [Related]
30. Radioimmunometric assay for hepatitis B surface antigen on the surface of infected cells.
Fukusato T; Thung SN; Gerber MA
J Immunol Methods; 1984 Dec; 75(2):325-32. PubMed ID: 6097612
[TBL] [Abstract][Full Text] [Related]
31. HBsAg retention sensitizes the hepatocyte to injury by physiological concentrations of interferon-gamma.
Gilles PN; Guerrette DL; Ulevitch RJ; Schreiber RD; Chisari FV
Hepatology; 1992 Sep; 16(3):655-63. PubMed ID: 1505908
[TBL] [Abstract][Full Text] [Related]
32. Intra- and extracellular distribution and immunochemical characterization of hepatitis B virus nucleocapsid proteins produced by a human hepatoma cell line transfected with cloned viral DNA.
Ohori H; Matsuda K
Virology; 1989 Jan; 168(1):40-7. PubMed ID: 2535906
[TBL] [Abstract][Full Text] [Related]
33. Metformin inhibits hepatitis B virus protein production and replication in human hepatoma cells.
Xun YH; Zhang YJ; Pan QC; Mao RC; Qin YL; Liu HY; Zhang YM; Yu YS; Tang ZH; Lu MJ; Zang GQ; Zhang JM
J Viral Hepat; 2014 Aug; 21(8):597-603. PubMed ID: 24164660
[TBL] [Abstract][Full Text] [Related]
34. Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA.
Foster GR; Ackrill AM; Goldin RD; Kerr IM; Thomas HC; Stark GR
Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2888-92. PubMed ID: 1707174
[TBL] [Abstract][Full Text] [Related]
35. Immunocytochemical investigation of hepatitis B virus-associated antigens in cases of liver cirrhosis and HBsAg antigenemia and their relationship to development of hepatocellular carcinoma.
Iwai M; Kashiwadani M; Okuno T; Takino T; Ibata Y
Histochem J; 1988 May; 20(5):283-9. PubMed ID: 2850288
[TBL] [Abstract][Full Text] [Related]
36. High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice.
Peng XH; Ren XN; Chen LX; Shi BS; Xu CH; Fang Z; Liu X; Chen JL; Zhang XN; Hu YW; Zhou XH
World J Gastroenterol; 2015 Mar; 21(12):3527-36. PubMed ID: 25834317
[TBL] [Abstract][Full Text] [Related]
37. Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response.
Chan HL; Wong VW; Tse AM; Tse CH; Chim AM; Chan HY; Wong GL; Sung JJ
Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1462-8. PubMed ID: 18054753
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C
Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247
[TBL] [Abstract][Full Text] [Related]
39. Lipid composition of hepatitis B virus surface antigen particles and the particle-producing human hepatoma cell lines.
Satoh O; Umeda M; Imai H; Tunoo H; Inoue K
J Lipid Res; 1990 Jul; 31(7):1293-300. PubMed ID: 2169517
[TBL] [Abstract][Full Text] [Related]
40. Hybrid hepatitis B virus-host transcripts in a human hepatoma cell.
Ou J; Rutter WJ
Proc Natl Acad Sci U S A; 1985 Jan; 82(1):83-7. PubMed ID: 2982146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
